Drug Discovery Informatics Market Size is expected to reach USD 7.44 billion by 2031, growing at a CAGR of 10.8%: Straits Research
March 18, 2024 09:30 ET
|
Straits Research Private Limited
New York, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Drug discovery informatics continues to revolutionize the field of drug discovery by leveraging cutting-edge technologies and...
Global Drug Discovery Market Size is Expected to Reach USD 120,809 million by 2030: Straits Research
December 05, 2023 10:10 ET
|
Straits Research
New York, United States, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Drug discovery is the process of examining potential novel treatments, and it takes place in the domains of pharmacology, biotechnology,...
Syntekabio (KOSDAQ:226330.KQ) Presents Neoantigen Prediction Technology at Cancer Immunotherapy Conference CICON22
September 26, 2022 15:07 ET
|
Syntekabio
New York, N.Y., United States, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ:226330.KQ), a global AI drug discovery and development company, will present its neoantigen prediction technology...
Shift Towards Personalized Medicines, Which Is Expected To Fuel The Growth Of The Antimicrobial Susceptibility Test Market
September 06, 2022 06:00 ET
|
FACT.MR
Dublin, Ireland, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: Rise in government initiatives related to the development of quality hospital...
InveniAI and Kyowa Kirin Announce Achievement of Milestone in Research Collaboration
May 31, 2022 08:15 ET
|
InveniAI LLC
GUILFORD, Conn. and TOKYO, May 31, 2022 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug and target discovery...
Antimicrobial Susceptibility Testing Market Worth $5.99 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
October 05, 2021 07:26 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Oct. 05, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Antimicrobial Susceptibility Testing Market by Product (Manual {Susceptibility Discs,...
InveniAI Appoints Industry Leader Dr. Salvatore Alesci as Chief Scientific Officer to Advance AI-Powered Portfolio of Assets Targeting Dysregulation of the Gut-Brain Axis
May 11, 2021 08:10 ET
|
InveniAI LLC
Pipeline to include new chemical entities as well as re-innovated drugs, all targeting dysregulation of the gut-brain axis and inflammasome pathways for chronic inflammatory diseasesDr. Alesci’s...
Global Antimicrobial Susceptibility Test Market Is Expected to Reach USD 7.57 billion by 2027 : Fior Markets
September 09, 2020 19:00 ET
|
Fior Markets
Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global antimicrobial susceptibility test market is expected to grow from USD 4.58 billion in 2019 and...
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
June 02, 2020 08:00 ET
|
InveniAI
GUILDFORD, Conn., June 02, 2020 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across...
InveniAI Introduces New Products to its AI-Powered Pharmaceutical Drug Discovery and Development Suite
November 06, 2019 08:00 ET
|
InveniAI
GUILFORD, Conn., Nov. 06, 2019 (GLOBE NEWSWIRE) -- InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation...